Evidence map›Paper›PMID 41455680›Full record

ArticleReproductive toxicology (Elmsford, N.Y.)2026

Corrigendum to "Hypothesis-driven approach to developmental toxicity assessment: Using mechanistic information to inform testing" [Reprod. Toxicol. 140 (2026) 109119].

George Daston, Matthew Burbank, Florian Gautier, Barbara F Hales, Amer Jamalpoor, Yasunari Kanda, Susan Makris, Aldert H Piersma, Nicola Powles-Glover, Sonya Sobrian and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Reproductive toxicology (Elmsford, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

George DastonGlobal Product Stewardship - Human Safety, The Procter & Gamble Co., Mason, OH 45040, USA.
Matthew BurbankL'Oréal Research and Innovation, France.
Florian GautierL'Oréal Research and Innovation, France.
Barbara F HalesDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Quebec H3G 1Y6, Canada.
Amer JamalpoorToxys, Leiden Bioscience Park, Oegstgeest, the Netherlands.
Yasunari KandaNational Institute of Health Sciences, Kawasaki, Japan.
Susan MakrisUS Environmental Protection Agency (Emeritus), Washington, DC, USA.
Aldert H PiersmaNational Institute for Public Health and the Environment (RIVM), Bilthoven, and Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, the Netherlands.
Nicola Powles-GloverKnoell Consulting Ltd., 22 Cathedral Road, Cardiff CF11 9LJ, United Kingdom.
Sonya SobrianHoward University, Washington, DC, USA.
Vicki SutherlandNational Institute of Environmental Health Sciences, Division of Translational Toxicology, Research Triangle Park, NC, USA.
Steven Van CruchtenUniversity of Antwerp, Antwerp, Belgium.
Ronald L WangeUS Food and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD 20993, USA.
Connie L ChenHealth and Environmental Sciences Institute, Washington, DC, USA. Electronic address: cchen@hesiglobal.org.

Funding

Intramural NIH HHS Z99 ES999999
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41455680
PMCPMC12958136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.